Rocket Pharmaceuticals, Inc. announces the closing of its previously announced underwritten public offering of 5,175,000 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 675,000 additional shares of its common stock, at a public offering price of $17.50 per share.
April 18, 2019
· 3 min read